Left ventricular myocardial hypertrophy. Pathogenetic issues

被引：0
|
作者：
Ryazanov, AS [1 ]
Smirnova, MD [1 ]
Yurenev, AP [1 ]
机构：
[1] AL Myasnikov Clin Cardiol Inst, Sci Consult Dept, Moscow, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2000年 / 72卷 / 02期
关键词：
review; left ventricle; myocardial hypertrophy; pathogenesis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 77
页数：6
相关论文
共 50 条
  • [1] Myocardial and plasma renin after left ventricular injury or hypertrophy.
    Katz, SA
    Opsahl, JA
    Heller, LJ
    Hirsch, AT
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1431 - A1431
  • [2] Ageing and regression of left ventricular hypertrophy.
    Du Cailar, G
    Ribstein, J
    Mimran, A
    REVUE DE MEDECINE INTERNE, 1998, 19 (12): : 870 - 877
  • [3] Myocardial glucose uptake is enhanced in essential hypertension induced left ventricular hypertrophy.
    Laine, H
    Nuutila, P
    Luotolahti, M
    Jula, A
    Kantola, I
    YkiJarvinen, H
    Knuuti, J
    DIABETOLOGIA, 1997, 40 : 1003 - 1003
  • [4] The peculiarity of disturbed myocardial fatty acid metabolism in patients with left ventricular hypertrophy.
    Isobe, N
    Toyama, T
    Hoshizaki, H
    Oshima, S
    Iizuka, T
    Kanazawa, N
    Wakamatsu, S
    Arisaka, H
    Suzuki, T
    Taniguchi, K
    Inoue, T
    Endo, K
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 846 - 846
  • [5] Left ventricular hypertrophy. Is there only hypertrophic cardiomyopathy?
    Lluch-Requerey, Carmen
    Montilla-Garrido, Miguel A.
    Morgado-Garcia-Polavieja, Jose I.
    Gragera-Martinez, Alvaro
    Gomez-Menchero, Antonio
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2024, 94 (01): : 123 - 126
  • [6] Therapeutic effects of irbesartan in left ventricular hypertrophy.
    Feraco, E
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 115A - 115A
  • [7] Improvement of ventricular performance in SHR by preventing left ventricular hypertrophy.
    Mill, JG
    Nascimento, MD
    Gomes, MD
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (09) : A7 - A7
  • [8] Ventriculoarterial coupling and left ventricular performance in hypertensive patients with left ventricular hypertrophy.
    Nitenberg, A
    Antony, I
    Loiseau, A
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1997, 90 (08): : 1025 - 1030
  • [9] Cessation of RhEPO therapy leads to recurrence of left ventricular hypertrophy.
    Sikole, A
    Polenakovik, M
    Spirovska, V
    Polenakovik, B
    Klinkmann, H
    Scigalla, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1250 - A1250
  • [10] Effect of Kidney Transplantation On Left Ventricular Remodeling and Risk Factors for Posttransplant Left Ventricular Hypertrophy.
    An, J.
    Hwang, J.
    Jeon, H.
    Jung, I.
    Park, S.
    Kim, Y.
    Kim, Y.
    Lee, J.
    TRANSPLANTATION, 2014, 98 : 121 - 121
12345